A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University

HDT Bio Canada Inc. partners with McGill University and The Neuro to advance HDT-401, an investigational locally administered RNA immune activator, into Phase 1 clinical evaluation for glioblastoma in Canada MONTREAL and SEATTLE, July 12, 2026 /PRNewswire/ — Among the deadliest of brain… Source: prnewswire Country: United States

Bronstein, Gewirtz & Grossman LLC Urges Megan Holdings Limited Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 12, 2026 /PRNewswire/ –Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Megan Holdings Limited (NASDAQ: MGN) and certain of its officers. This lawsuit seeks to recover damages… Source: prnewswire Country: United States

Liquidity slows down in first 4 months of 2026 – BoG

According to its May 2026 Monetary Policy Report (MPR), the moderation in broad money growth was largely driven by a significant decline in the contribution of Net Foreign Assets (NFA). However, this was partly offset by stronger growth in the Net Domestic Assets (NDA). Source: ghana-business Country: Ghana

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference®

New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partners TOKYO and CAMBRIDGE, Mass., July 12, 2026 /PRNewswire/ — Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB)… Source: prnewswire Country: United States